Oriental Pharmaceutical Industries Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
as on 17-06-2024
- Paid Up Capital ₹ 0.64 M
as on 17-06-2024
- Company Age 83 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 50.27 Cr
as on 17-06-2024
- Satisfied Charges ₹ 25.00 Cr
as on 17-06-2024
- Revenue -10.84%
(FY 2022)
- Profit -130.27%
(FY 2022)
- Ebitda -65.10%
(FY 2022)
- Net Worth -1.67%
(FY 2022)
- Total Assets -5.20%
(FY 2022)
About Oriental Pharmaceutical Industries
The Corporate was formerly known as The Oriental Pharmaceutical Industries Limited. The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 0.64 M.
The company currently has active open charges totaling ₹50.27 Cr. The company has closed loans amounting to ₹25.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Youhaan Kapadia, Dhau Lambore, and Amol Kapadia serve as directors at the Company.
- CIN/LLPIN
U24239MH1941PLC003286
- Company No.
003286
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
11 Mar 1941
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Vishalgad, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Oriental Pharmaceutical Industries?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Youhaan Kapadia  | Additional Director | 15-Feb-2024 | Current |
| Dhau Lambore | Director | 13-Feb-2014 | Current |
| Amol Kapadia | Director | 01-Sep-1995 | Current |
Financial Performance and Corporate Structure Insights of Oriental Pharmaceutical Industries.
Oriental Pharmaceutical Industries Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 10.84% decrease. The company also saw a substantial fall in profitability, with a 130.27% decrease in profit. The company's net worth dipped by a decrease of 1.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oriental Pharmaceutical Industries?
In 2022, Oriental Pharmaceutical Industries had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Coriander Industries Private LimitedActive 32 years 4 monthsYouhaan Kapadia and Amol Kapadia are mutual person
Europa Chemicals Asia Private LimitedActive 12 years 5 monthsYouhaan Kapadia and Amol Kapadia are mutual person
- Polson Butter Private LimitedActive 14 years 18 days
Dhau Lambore and Amol Kapadia are mutual person
Mathiesen Chemeasy Private LimitedActive 7 months 25 daysYouhaan Kapadia and Amol Kapadia are mutual person
- Coriander Specialities Private LimitedActive 18 years 7 months
Youhaan Kapadia and Amol Kapadia are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 29 Dec 2017 | ₹23.00 Cr | Open |
Hdfc Bank Limited Creation Date: 10 Nov 2017 | ₹27.27 Cr | Open |
Kotak Mahindra Bank Limited Creation Date: 31 Mar 2015 | ₹25.00 Cr | Satisfied |
How Many Employees Work at Oriental Pharmaceutical Industries?
Unlock and access historical data on people associated with Oriental Pharmaceutical Industries, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oriental Pharmaceutical Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oriental Pharmaceutical Industries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
